Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03899844 · ClinicalTrials.gov registry record
Study to Evaluate Amyloid in Blood and Imaging Related to Dementia
A clinical trial, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- 1,122
- Enrollment target
NCT03899844 is a clinical trial that has completed, run by Washington University School of Medicine. The registered enrollment target is 1,122 participants.
The verdict
NCT03899844 has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- 1,122 participants
- Enrollment target
Study Summary
The purpose of this study is to determine how well a blood test can detect amyloid beta, a protein involved in Alzheimer's disease. Participants will be asked to complete an initial blood collection and cognitive testing, and a subset of participants will be asked to complete a larger blood collection, amyloid PET imaging, and an MRI.
Interventions
- OTHER Blood collection, PiB PET/MRI, and cognitive testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,122 participants |
| Start Date | 2019-04-09 |
| Est. Completion | 2024-01-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03899844
The ClinicalTrials.gov registry entry for NCT03899844 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,122 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Blood collection, PiB PET/MRI, and cognitive testing is the first listed.
NCT03899844 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03899844 about?
NCT03899844 is a clinical study titled "Study to Evaluate Amyloid in Blood and Imaging Related to Dementia". The purpose of this study is to determine how well a blood test can detect amyloid beta, a protein involved in Alzheimer's disease. Participants will be asked to complete an initial blood collection and cognitive testing, and a subset of participants will be asked to complete a larger blood collecti...
What is the current status of trial NCT03899844?
This trial is currently completed. The enrollment target is 1,122 participants. The study started on 2019-04-09. Estimated completion is 2024-01-31.
What interventions are being tested in trial NCT03899844?
The interventions under investigation include: Blood collection, PiB PET/MRI, and cognitive testing (OTHER).
Who is sponsoring clinical trial NCT03899844?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.